Cite
HARVARD Citation
Lamar, Z. et al. (2018). Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration – a retrospective study. Leukemia & lymphoma. 59 (8), pp. 1871-1877. [Online].